On 27 November 2020 Barcelona Commercial Court Number 1 dismissed the second preliminary injunction request filed by Sanofi against Mylan in relation to an insulin glargine biosimilar product.
Second preliminary injunction request based on amended form of patent dismissed
1 archivo(s) 117.54 KB
